Medical Strategy is one of Europe’s leading independent healthcare investment managers. The company focuses exclusively on managing and advising healthcare equity portfolios as part of its core competency.
The primary objective of Medical Strategy is to identify innovations in the healthcare sector at an early stage in order to generate above-average long-term results for investors by investing in low-rated growth companies. An in-house database systematically documents and analyzes more than 900 companies from the international healthcare sector and is continuously expanded through proprietary research as well as external specialized studies.
A flexible investment approach is pursued, with access to all segments of the healthcare sector. Investment decisions are not guided by standardized benchmarks, but by targeted investments in companies that are not exposed to declining revenues and that demonstrate strong potential for value creation driven by innovation.
The team is composed of experts with complementary backgrounds and decades of combined experience in both the healthcare and financial sectors. This results in a deep understanding of scientific developments as well as investment-relevant trends in the healthcare market. Listed companies across all relevant healthcare segments are analyzed on an ongoing basis.
As an owner-managed company, decisions are made with full independence. The firm has been a member of the Association of Independent Asset Managers (VuV) since 2002 and has been licensed for financial portfolio management by the Federal Financial Supervisory Authority (BaFin) since 1998.
Suscríbete a nuestra newsletter
Si quieres mantenerte informado de las actualizaciones y novedades de nuestros servicios y productos ...
Entidad Regulada

Contacto
Puedes ponerte en contacto con nosotros en el correo brightgate@brightgatecapital.com o través del siguiente formulario de contacto.
C/ Génova, 11 4º Izda.
28004, Madrid. España.
Teléfono: +34 91 441 00 11
Fax: +34 91 434 77 94